Fresenius Kabi announced it has introduced Plerixafor Injection, a generic equivalent to Mozobil®, available immediately in the United States in a 24 mg per...
Fresenius Kabi announced the immediate availability in the U.S. of Stimufend, the company’s biosimilar to Neulasta, for use in patients at risk for febrile...
